Dominion Aesthetic Technologies Inc reported on Tuesday the receipt of US FDA clearance for its medical, non-contact body contouring product, eon FR.
The company added that the eon FR is capable of reducing fat over a larger surface area than its competitors, which is highly desired by both physicians and patients. The body shaping technology delivers non-contact, laser energy to reduce fat in the abdomen using a patent-pending powered articulated arm.
According to the company, the eon FR causes the death of fat cells through apoptosis process that takes from six to 12 weeks and after the eon FR body contouring treatment, the body naturally eliminates fat cells through its lymphatic system. The treatment takes about 15 minutes to perform with no downtime.
Headquartered in San Antonio, TX, the laser-based medical device company offers the best innovative tools to serve the physicians' practices and the patients' needs.
Getinge launches Fluobeam LS for fluorescence‑guided small‑incision surgery
Airiver Medical treats first chronic rhinosinusitis patient in Drug Coated Balloon clinical study
Galmed Pharmaceuticals to acquire Colospan for GI-focused platform development
Medtronic seeks expanded US approvals for Hugo robotic surgery system
Waters secures FDA clearance for BD BACTEC FXI Blood Culture System
MiniMed expands Abbott partnership for dual glucose-ketone diabetes sensors
ILC Dover adds Water for Injection (WFI) and custom chemical solutions to offerings
Merz Therapeutics and Kvvit sign exclusive agreement for INBRIJA in Greater China
Implantica submits final FDA response for RefluxStop PMA application
Artivion completes acquisition of Endospan following FDA approval of NEXUS Aortic Arch System